The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.
about
Allergenicity of carbohydrates and their role in anaphylactic events.The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactoseImmunogenicity of Biotherapeutics: Causes and Association with Posttranslational ModificationsEnzyme-labeled Antigen Method: Development and Application of the Novel Approach for Identifying Plasma Cells Locally Producing Disease-specific Antibodies in Inflammatory LesionsUse of genetically-engineered pig donors in islet transplantationCancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reactionImmunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trialsNovel adjuvant therapies for pancreatic adenocarcinomaComparison of Porcine Small Intestinal Submucosa versus Polypropylene in Open Inguinal Hernia Repair: A Systematic Review and Meta-AnalysisDelayed anaphylaxis to red meat in patients with IgE specific for galactose alpha-1,3-galactose (alpha-gal).The alpha-gal story: lessons learned from connecting the dots.Role of α-gal epitope/anti-Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancerCurrent progress of genetically engineered pig models for biomedical researchIncreased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and CirrhosisThe red meat allergy syndrome in SwedenCharacteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review)Galactose-α-1,3-Galactose: Atypical Food Allergen or Model IgE Hypersensitivity?Delayed Anaphylaxis Involving IgE to Galactose-alpha-1,3-galactose.Anaphylaxis to the carbohydrate side chain alpha-galPorcine or bovine valve replacement in 3 patients with IgE antibodies to the mammalian oligosaccharide galactose-alpha-1,3-galactose.Delayed clinical and ex vivo response to mammalian meat in patients with IgE to galactose-alpha-1,3-galactoseEmerging antigens involved in allergic responses.Determinants of food allergy.Galactose-α-1,3-galactose-specific IgE is associated with anaphylaxis but not asthma.Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactoseAnaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant.Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.Correlated effects of selection for immunity in White Leghorn chicken lines on natural antibodies and specific antibody responses to KLH and M. butyricumB-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation.Tick-host conflict: immunoglobulin E antibodies to tick proteins in patients with anaphylaxis to tick biteIgE-based immunotherapy of cancer: challenges and chances.Metabolic engineering of Agrobacterium sp. strain ATCC 31749 for production of an alpha-Gal epitope.Rapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healingAmblyomma sculptum tick saliva: α-Gal identification, antibody response and possible association with red meat allergy in Brazil.Bridging innate and adaptive antitumor immunity targeting glycans.A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki diseaseMechanical compliance and immunological compatibility of fixative-free decellularized/cryopreserved human pericardiumSpecific effects of BCL10 Serine mutations on phosphorylations in canonical and noncanonical pathways of NF-κB activation following carrageenan.Competition between serum IgG, IgM, and IgA anti-glycan antibodiesExposure to common food additive carrageenan alone leads to fasting hyperglycemia and in combination with high fat diet exacerbates glucose intolerance and hyperlipidemia without effect on weight.
P2860
Q24599525-5A8EE87F-1914-4D5C-89B6-01A21E4D5A1CQ24604244-B6951840-1C42-40F7-B8FF-43A931F3878CQ26738810-1C68CC50-3B28-463D-8979-EC1E24804BAFQ26752509-6D2BD236-D813-4655-8A42-99136271633CQ26771395-DDD4D784-88AE-418E-8A59-8B6F2255B728Q26777542-D6BC08FE-80A1-4242-96A7-93883AE4DEC1Q26781538-29F45B0B-5C3D-41C8-B3AE-C338A3F580A4Q26799425-6BD2ACFE-4718-4DA0-9E96-F6623F1DAAB3Q26801058-6018E41E-4EC5-4CE1-8FF1-969516DD39EDQ26995957-8FB918AB-FCEE-4136-9B0C-08BB2C9DAF9EQ27023451-00B85CC6-7541-488A-84D8-A0DC7D5C31DCQ27024368-9E6D64DB-D780-4761-A40C-EA99DFC11406Q27027327-19E3C451-870E-4DAF-B0A5-A453DC115D9CQ27485310-58867AE8-0C90-4F4B-BFC5-B5D8101B985DQ28074633-DA176EDF-9FBC-49C8-91F7-CFD882866493Q28084522-D075E7E5-7D08-4FFC-A05D-BB4DA99276C0Q30274707-8F990BF2-76E1-4D8F-84DC-987250A259BBQ30279084-457A0219-A52F-4931-9DF6-C9C9481293D0Q30300243-7146BC2F-0333-4433-B8A2-828DA885CFF8Q30371120-47E4305D-55AC-458E-ACAE-42A0B7771500Q30384427-B37BC614-D694-4920-BDFE-0B74E172FC5CQ30409225-847D6374-1C87-46F4-996A-E5E60BA9A469Q30422603-5D5B46BA-AAA2-497C-8F3C-F896C25A60EAQ30424672-11FF603A-FD2A-43F4-B085-699063A7703AQ30427410-3A05FC2B-12CC-4FC3-9A28-6FF100A9C0CBQ30434648-BF1150D9-4E0A-4D19-B4A7-8AA57F2DBDC8Q30441575-02A9B8BA-F3B6-4F88-B66D-25E4E4C165A5Q33314651-1F42E907-B377-4567-B017-B8975ED5B4D3Q33581388-6FC030C8-A7C5-4C7E-9E0A-DE50F22C5713Q33591274-258C4B4E-C126-4817-9578-43BF2BAEEBB7Q33619979-4910EC8B-5216-4531-8428-2A942516B261Q33638602-3008F711-0CCD-4F4B-A32A-E0799A7664E1Q33881766-97523F23-BA14-4BDD-A139-20F53FCB571BQ33924413-7D6F865C-C368-422B-BACC-96F0D1B36956Q33960021-7B9FE43F-B5CB-4887-9D94-64CB1B4CC95DQ34631810-CC744985-E56E-43F4-B54F-16D2883A8E0FQ34738186-D3765B5F-2B40-4729-9670-94CF6D618240Q35216729-F671079D-E1DB-4A66-B67F-196C7536DC9DQ35217313-0965DBB5-DA48-470B-888D-8507EF0A7BF2Q35324612-C7CAFEF3-E83E-4E0C-BB91-69305CFF6145
P2860
The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The alpha-gal epitope and the ...... n and in cancer immunotherapy.
@ast
The alpha-gal epitope and the ...... n and in cancer immunotherapy.
@en
The alpha-gal epitope and the ...... n and in cancer immunotherapy.
@nl
type
label
The alpha-gal epitope and the ...... n and in cancer immunotherapy.
@ast
The alpha-gal epitope and the ...... n and in cancer immunotherapy.
@en
The alpha-gal epitope and the ...... n and in cancer immunotherapy.
@nl
prefLabel
The alpha-gal epitope and the ...... n and in cancer immunotherapy.
@ast
The alpha-gal epitope and the ...... n and in cancer immunotherapy.
@en
The alpha-gal epitope and the ...... n and in cancer immunotherapy.
@nl
P1476
The alpha-gal epitope and the ...... n and in cancer immunotherapy.
@en
P2093
Uri Galili
P304
P356
10.1111/J.1440-1711.2005.01366.X
P577
2005-12-01T00:00:00Z